Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel solvent-free method reduces cost and improves safety for pharmaceutical intermediate manufacturing supply chains globally.
Novel patent CN119409702A enables safer dipyridamole intermediate production with high purity and reduced hazardous waste for reliable pharmaceutical intermediates supplier partnerships.
Patent CN1325392A reveals a novel process for branched carboxylic acid glycidyl esters, offering superior color stability and cost reduction in coating additive manufacturing.
Patent CN1325392A reveals a breakthrough process for branched glycidyl esters, offering superior color stability and yield preservation for reliable coatings intermediate supply chains.
Patent CN100591674C reveals a safe tungstate-catalyzed route for 5-substituted tetrazoles, offering high yields and recyclable catalysts for reliable pharmaceutical intermediate supply.
Patent CN112961194A discloses novel tridentate PNO ligands enabling high ee and yield in ketone hydrogenation, offering robust supply chain solutions for pharma intermediates.
Novel green synthesis route for Beclomethasone dipropionate intermediates offering high purity >99.5% and reduced wastewater for pharmaceutical manufacturing.
Patent CN101891677B reveals a green 2-step route to Mexidole using solid superacids. Achieve high purity and cost reduction in API manufacturing with scalable technology.
Patent CN112521328A details a high-purity 3-bromocarbazole method using Br-/O2 2- system, offering cost reduction and scalable supply for electronic and pharma sectors.
Advanced synthesis of 1-carboxamido-1-cyclopropanecarboxylic acid via mild ammoniation. High-yield agrochemical intermediate for plant growth regulation and supply chain optimization.
Patent CN117383996B reveals selective deuteration method. Offers high yield and simplified supply chain for pharmaceutical intermediate manufacturing.
Novel patent CN105461671B enables cost-effective high-purity intermediate production with simplified supply chain and scalable manufacturing processes for global buyers.
Patent CN115403562A reveals a scalable route for 4-halopyridine bis-imidazole ligands, offering high purity without column chromatography for advanced material manufacturing.
Patent CN103570600B reveals Pd-catalyzed asymmetric amination for chiral beta-lactams. Enables cost reduction in pharmaceutical manufacturing with high enantioselectivity.
Patent CN102212572B details a yeast-displayed lipase method for L-ascorbyl oleate. Achieve higher purity and cost efficiency in antioxidant manufacturing with this novel biocatalytic route.
Patent CN110759836B reveals a metal-free fluoroalkylation method using acetone and visible light, offering cost-effective synthesis for high-purity pharmaceutical intermediates.
Novel Cu/Ir synergistic catalysis for stereo-diverse tetrahydro-γ-carbolines. High yield, mild conditions, scalable pharmaceutical intermediate manufacturing.
Patent CN113354554B details an efficient Iridium-catalyzed asymmetric hydrogenation route for carbapenem intermediates, offering superior stereoselectivity and scalable manufacturing capabilities.
Patent CN106995467A reveals microwave synthesis for Bicycloplatin. Discover cost reduction in pharmaceutical manufacturing and reliable supply chain solutions.
Patent CN116813659A introduces a threonine-based chiral catalyst enabling high enantioselectivity and cost-effective manufacturing for complex pharmaceutical intermediates.